Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729. Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503. Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Aug 2006 Prescribing a Teratogenic Medication Jeffrey M. Weinberg, MD Virtual Mentor. 2006;8(8):495-498. doi: 10.1001/virtualmentor.2006.8.8.ccas3-0608. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729.
Case and Commentary Mar 2005 Drug Testing in Adolescents Todd S. Varness, MD, MPH and Norman Fost, MD, MPH Virtual Mentor. 2005;7(3):208-212. doi: 10.1001/virtualmentor.2005.7.3.ccas1-0503.
Case and Commentary Mar 2005 An Adolescent with an Eating Disorder Garry Sigman, MD Virtual Mentor. 2005;7(3):213-217. doi: 10.1001/virtualmentor.2005.7.3.ccas2-0503.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Aug 2006 Prescribing a Teratogenic Medication Jeffrey M. Weinberg, MD Virtual Mentor. 2006;8(8):495-498. doi: 10.1001/virtualmentor.2006.8.8.ccas3-0608.